- Cite this article as:
- Boulos, P., Ioannidis, G. & Adachi, J.D. Curr Rheumatol Rep (2000) 2: 53. doi:10.1007/s11926-996-0069-4
This article attempts to evaluate the results of several recently published clinical trials of drugs used in the treatment and prevention of glucocorticoid-induced osteoporosis. Despite our lack of understanding regarding the biological mechanisms that lead to glucocorticoid-induced bone loss, effective therapy has been developed. Bisphosphonates have demonstrated significant treatment benefits and should be considered the therapy of choice for both the treatment and prevention of glucocorticoid-induced osteoporosis.